From the point of healthy dominance to inspect medical device industry in Taiwan - A case study of CX company

• Main Authors: Liu, Jungtung, 劉榮東
• Other Authors: Hsieh, Tenglung
• Format: Others
• Language: zh-TW
• Published: 2012
• Online Access: http://ndltd.ncl.edu.tw/handle/99668239310153357980

碩士 === 東海大學 === 管理碩士在職專班 === 100 === In the past 30 years, medical device industry was regarded as another economic miracle by Taiwan government. In recent years, although the trade quantity of medical devices had a slight increase, the majority of products were classified as low-end or easily-involved equipment such as blood sugar testing machine, blood pressure monitor or electric wheelchair. These products have not only narrow profits, but have no much help for medical care quality upgrading. In fact, as Dr. 翁啟惠Academia Sinica Dean said, the outcome of development on medical device in Taiwan was disappointed. Before 1949, the medical system in Taiwan was established by Japan. Since then, English becomes a major foreign language by education system due to the government encouraged, the medical caring model and knowledge sources were shifted to US-based healthy system. Most of medical-related materials were imported from US or other countries which were licensed by FDA. There are almost no high-end equipments which were designed or manufactured in Taiwan. People will pay higher cost to maintain our healthy system, on the other hand, Taiwan would not be able to dominate the trends of medical care. The nature of healthy care should be interacted with economic activities. How to integrate the energy of government, industry and academia to formulate a workable policy is the main discourse of this article. This paper was assembled and summarized aspirations by interviewing a key CEO of a selected high-tech domestic company, 20 experienced clinical practitioners and analysis the success factors of foreign companies and made following conclusions: (A)The policy-making should be included the characteristics of the domestic medical industry, the R & D performance of academia, revising and discarding the outdated regulation. (B)The industry has to respect the value of intellectual properties and provide an attractive incentives to inspire the medical practitioners to join R & D. (C)Practitioners should be kept in mind to find out the possible way to resolve the medical drawback anytime.